ArticleTransfusion medicine (Oxford, England)2021
Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients.
Abstract readLetterComment
In one paragraph
Article in Transfusion medicine (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
0.4field-weighted citation impact, top 26% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 14 citations in OpenAlex.
- COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.JAMA network open · 2023Pooled it
- The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis.Mayo Clinic proceedings · 2021Pooled it
- Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.JMIR public health and surveillance · 2021Pooled it
- Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.The Journal of clinical investigation · 2021Trial
- Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update.Process biochemistry (Barking, London, England) · 2023Review
- Use of convalescent plasma in COVID-19 patients with immunosuppression.Transfusion · 2021Review
- High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies.Leukemia research · 2021Article
- Passive Immunity Should and Will Work for COVID-19 for Some Patients.Clinical hematology international · 2021Review
- A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.Medical science monitor : international medical journal of experimental and clinical research · 2020Observational
- Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.Frontiers in pharmacology · 2020Review
Corrections and comments
- Comment on
Authors and funding
27 authors at 3 institutions in 1 country.
Priya PalDeming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Moayed IbrahimSection of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Alex NiuSection of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Kevin J ZwezdarykDepartment of Microbiology and Immunology, Tulane University, New Orleans, Louisiana, USA.
Elise TatjeClinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
William R RobinsonClinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
Leta KoClinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
Ishwarya SatyavarapuClinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
Wallace E JonesDeming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Adeem NachabeDepartment of Medicine, Louisiana State University School of Medicine, New Orleans, Louisiana, USA.ORCID 0000-0003-4683-5831
Alfred LukSection of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
David M MushattSection of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Karin HalvorsonSection of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Joshua L DensonSection of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Charles C SmithDepartment of Pulmonary Diseases, Touro LCMC Health, New Orleans, Louisiana, USA.
Francesco SimeoneSection of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Gaynelle DavisClinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
Sukhmani K GillSection of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
April McDougalSection of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Aniko S VighClinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
Tim G PetersonSection of Pathology and Laboratory Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Bo NingDepartment of Biochemistry and Molecular Biology, Tulane University, New Orleans, Louisiana, USA.
Tony HuDepartment of Biochemistry and Molecular Biology, Tulane University, New Orleans, Louisiana, USA.
Francisco SocolaSection of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.ORCID 0000-0002-4002-9284
James RobinsonSection of Pediatric Infectious Disease, Department of Pediatrics, Tulane University, New Orleans, Louisiana, USA.
Hana SafahSection of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
Nakhle S SabaSection of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.ORCID 0000-0003-3206-2575
Tulane University · USLouisiana State Department of Health and Hospitals · USLouisiana State University · US
Funding
Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1MNIGMS NIH HHS U54 GM104940
Abstract
PubMed holds no abstract for this paper.
Indexed as
Coronavirus InfectionsCOVID-19COVID-19 SerotherapyHumansImmunization, PassiveImmunoglobulinsSARS-CoV-2Immunoglobulins
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.